Report Detail
Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Medical Devices Pipeline Assessment, 2019
- RnM3864403 |
- 10 January, 2020 |
- Global |
- 157 Pages |
- GlobalData |
- Medical Devices & Consumables
Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Medical Devices Pipeline Assessment, 2019
Summary
GlobalData's Medical Devices sector report, “Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Medical Devices Pipeline Assessment, 2019" provides an overview of Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
- 1.1 List of Tables 6
- 1.2 List of Figures 9
2 Introduction 10
- 2.1 Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters Overview 10
3 Products under Development 11
- 3.1 Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products by Stage of Development 11
- 3.2 Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products by Territory 12
- 3.3 Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products by Regulatory Path 13
- 3.4 Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products by Estimated Approval Date 14
- 3.5 Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Ongoing Clinical Trials 15
4 Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products under Development by Companies 16
- 4.1 Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters Companies - Pipeline Products by Stage of Development 16
- 4.2 Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products by Stage of Development 17
5 Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters Companies and Product Overview 19
- 5.1 AnGes Inc Company Overview 19
- 5.1.1 AnGes Inc Pipeline Products & Ongoing Clinical Trials Overview 19
- 5.2 AngioCure, Inc. Company Overview 21
- 5.2.1 AngioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
- 5.3 Boston Scientific Corp Company Overview 22
- 5.3.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 22
- 5.4 Cardionovum GmbH Company Overview 27
- 5.4.1 Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview 27
- 5.5 Concept Medical Inc Company Overview 31
- 5.5.1 Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 31
- 5.6 Contego Medical LLC Company Overview 34
- 5.6.1 Contego Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 34
- 5.7 eucatech AG Company Overview 35
- 5.7.1 eucatech AG Pipeline Products & Ongoing Clinical Trials Overview 35
- 5.8 Lifetech Scientific (Shenzhen) Co Ltd Company Overview 36
- 5.8.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
- 5.9 Lutonix Inc Company Overview 39
- 5.9.1 Lutonix Inc Pipeline Products & Ongoing Clinical Trials Overview 39
- 5.10 M.A. Med Alliance SA Company Overview 44
- 5.10.1 M.A. Med Alliance SA Pipeline Products & Ongoing Clinical Trials Overview 44
- 5.11 Medtronic plc Company Overview 45
- 5.11.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 45
- 5.12 Micell Technologies Inc Company Overview 49
- 5.12.1 Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 49
- 5.13 Orchestra BioMed Inc Company Overview 50
- 5.13.1 Orchestra BioMed Inc Pipeline Products & Ongoing Clinical Trials Overview 50
- 5.14 Pulsus Medical LLC (Inactive) Company Overview 51
- 5.14.1 Pulsus Medical LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 51
- 5.15 QT Vascular Ltd Company Overview 52
- 5.15.1 QT Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 52
- 5.16 QualiMed Innovative Medizinprodukte GmbH Company Overview 56
- 5.16.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview 56
- 5.17 SiL Vascular Ltd Company Overview 57
- 5.17.1 SiL Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 57
- 5.18 Spectranetics Corp Company Overview 58
- 5.18.1 Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview 58
- 5.19 SurModics Inc Company Overview 65
- 5.19.1 SurModics Inc Pipeline Products & Ongoing Clinical Trials Overview 65
- 5.20 Tailored Medical Devices Inc Company Overview 72
- 5.20.1 Tailored Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 72
- 5.21 TransMed7 LLC Company Overview 73
- 5.21.1 TransMed7 LLC Pipeline Products & Ongoing Clinical Trials Overview 73
- 5.22 Vascular Nanotransfer Technologies Company Overview 74
- 5.22.1 Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview 74
6 Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Recent Developments 76
- 6.1 Nov 22, 2019: Medtronic receives FDA approval for IN.PACT AV DCB 76
- 6.2 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 76
- 6.3 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 79
- 6.4 Nov 12, 2019: Cardiovascular Systems announces Stephen Stenbeck joins Board of Directors 80
- 6.5 Nov 12, 2019: Cook Medical’s leadership updates in Asia-pacific reinforce focus on growth and physician relationships 80
7 Appendix 154
- 7.1 Methodology 154
- 7.2 About GlobalData 157
- 7.3 Contact Us 157
Summary:
Get latest Market Research Reports on Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters. Industry analysis & Market Report on Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters is a syndicated market report, published as Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Medical Devices Pipeline Assessment, 2019. It is complete Research Study and Industry Analysis of Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
